A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: Changes in smoking behavior and readiness to quit

Nicotine and Tobacco Research

Volumn 12, Issue 2, 2010, Pages 136-143

  Carpenter, Matthew J ^a   Gray, Kevin M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO CHANGE; ATTITUDE TO HEALTH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HICCUP; HUMAN; INSOMNIA; MALE; NAUSEA; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF CONCEPT; SMOKELESS TOBACCO; SMOKING; SMOKING CESSATION;

ADULT; BEHAVIOR, ADDICTIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; NICOTINE; PILOT PROJECTS; SELF EFFICACY; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER; TOBACCO, SMOKELESS;

EID: 77950235891     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntp186     Document Type: Article

References (42)

1. Biener, L., & Abrams, D. B. (1991). The contemplation ladder: Validation of a measure of readiness to consider smoking cessation. Health Psychology, 10, 360-365.
2. Biener, L., Bogen, K., & Connolly, G. (2007). Impact of corrective health information on consumers' perceptions of "reduced exposure" tobacco products. Tobacco Control, 16, 306-311.
3. Blank, M. D., Sams, C., Weaver, M. F., & Eissenberg, T. (2008). Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers. Nicotine & Tobacco Research, 10, 417-421.
4. Caraballo, R. S., Pederson, L. L., & Gupta, N. (2006). New tobacco products: Do smokers like them? Tobacco Control, 15, 39-44.
5. Carpenter, M. J., Hughes, J. R., Solomon, L. J., & Callas, P. W. (2004). Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. Journal of Consulting and Clinical Psychology, 72, 371-381.
6. Farkas, A. J., Gilpin, E. A., Distefan, J. M., & Pierce, J. P. (1999). The effects of household and workplace smoking restrictions on quitting behaviours. Tobacco Control, 8, 261-265.
7. Foulds, J., Ramstrom, L., Burke, M., & Fagerstrom, K. (2003). Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tobacco Control, 12, 349-359.
8. Furberg, H., Bulik, C., Lerman, C., Lichtenstein, P., Pedersen, N., & Sullivan, P. (2005). Is Swedish snus associated with smoking initiation or smoking cessation? Tobacco Control, 14, 422-424.
9. Furberg, H., Lichtenstein, P., Pedersen, N. L., Bulik, C. M., Lerman, C., & Sullivan, P. F. (2007). Snus use and other correlates of smoking cessation in the Swedish Twin Registry. Psychological Medicine, 38, 1299-1308.
10. Gilljam, H., & Galanti, M. R. (2003). Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden. Addiction, 98, 1183-1189.
11. Gwaltney, C. J., Metrik, J., Kahler, C. W., & Shiffman, S. (2009). Self-efficacy and smoking cessation: A meta-analysis. Psychology of Addictive Behaviors, 23, 56-66.
12. Hamilton, W. L., Norton, G. D., Ouellette, T. K., Rhodes, W. M., Kling, R., & Connolly, G. N. (2004). Smokers' responses to advertisements for regular and light cigarettes and potential reduced-exposure tobacco products. Nicotine & Tobacco Research, 6(Suppl. 3), S353-S362.
13. Hatsukami, D. K., Benowitz, N. L., Rennard, S. I., Oncken, C., & Hecht, S. S. (2006). Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine & Tobacco Research, 8, 169-191.
14. Hatsukami, D. K., Ebbert, J. O., Feuer, R. M., Stepanov, I., & Hecht, S. S. (2007). Changing smokeless tobacco products: New delivery systems. American Journal of Preventive Medicine, 33, S368-S378.
15. Hatsukami, D. K., Joseph, A. M., LeSage, M., Jensen, J., Murphy, S. E., Pentel, P. R., et al. (2008). Developing the science base for reducing tobacco harm. Nicotine & Tobacco Research, 9, S537-S553.
16. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K.-O. (1991). The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127.
17. Hecht, S. S., Carmella, S. G., Murphy, S. E., Riley, W. T., Le, C., Luo, X., et al. (2007). Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiology Biomarkers & Prevention, 16, 1567-1572.
18. Hickman, N., Klonoff, E. A., Landrine, H., Kashima, K., Parekh, B., Fernandez, S., et al. (2004). Preliminary investigation of the advertising and availability of PREPs, the new "safe" tobacco products. Journal of Behavioral Medicine, 27, 413-424.
19. Hughes, J. R. (2001). Do "light" cigarettes undermine cessation? Tobacco Control, 10, ip41-ip42.
20. Hughes, J. R., & Hatsukami, D. (1986). Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43, 289-294.
21. Hund, L. M., Farrelly, M. C., Allen, J. A., Chou, R. H., St. Claire, A. W., Vallone, D. M., et al. (2006). Findings and implications from a national study on potential reduced exposure products (PREPs). Nicotine & Tobacco Research, 8, 791-797.
22. Kotlyar, M., Mendoza-Baumgart, M. I., Li, Z., Pentel, P. R., Barnett, B. C., Feuer, R. M., et al. (2007). Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge. Tobacco Control, 16, 138-142.
23. Liang, K. Y., & Zeger, S. L. (1986). Longitudinal data analysis using generalized linear models. Biometrika, 73, 13-22.
24. Mendoza-Baumgart, M. I., Tulunay, O. E., Hecht, S. S., Zhang, Y., Murphy, S., Le, C., et al. (2007). Pilot study on lower nitrosaminesmokeless tobacco products compared with medicinal nicotine. Nicotine & Tobacco Research, 9, 1309-1323.
25. Norman, G. J., Ribisl, K. M., Howard-Pitney, B., Howard, K. A., & Unger, J. B. (2000). The relationship between home smoking bans and exposure to state tobacco control efforts and smoking behaviors. American Journal of Health Promotion, 15, 81-88.
26. O'Connor, R. J., Hyland, A., Giovino, G. A., Fong, G. T., & Cummings, K. M. (2005). Smoker awareness of and beliefs about supposedly less harmful tobacco products. American Journal of Preventive Medicine, 29, 85-90.
27. Parascandola, M., Hurd, A. L., & Augustson, E. (2008). Consumer awareness and attitudes related to new potential reduced-exposure tobacco products. American Journal of Health Behavior, 32, 431-437.
28. Pederson, L. L., & Nelson, D. (2007). Literature review and summary of perceptions, attitudes, beliefs, and marketing of potentially reduced exposure products: Communication implications. Nicotine & Tobacco Research, 9, 525-534.
29. Prochaska, J. O., Velicer, W. F., DiClemente, C. C., & Fava, J. L. (1988). Measuring processes of change: Applications to the cessation of smoking. Journal of Consulting and Clinical Psychology, 56, 520-528.
30. Sherer, G. (2006). Carboxyhemoglobin and thiocyanate as biomarkers of exposure to carbon monoxide and hydrogen cyanide in tobacco smoke. Health Psychology, 3, 563-581.
31. Shields, P. G. (2002). Tobacco smoking, harm reduction, and biomarkers. Journal of the National Cancer Institute, 94, 1435-1444.
32. Shiffman, S., Gitchell, J., Rohay, J. M., Hellebusch, S. J., & Kemper, K. E. (2007). Smokers' preferences for medicinal nicotine vs smokeless tobacco. American Journal of Health Behavior, 31, 462-472.
33. Shiffman, S., Jarvis, M. J., Pillitteri, J. L., Di Marino, M. E., Gitchell, J. G., & Kemper, K. E. (2007). UK smokers' and ex-smokers' reactions to cigarettes promising reduced risk. Addiction, 102, 156-160.
34. Shiffman, S., Pillitteri, J. L., Burton, S. L., & DiMarino, M. E. (2004). Smoker and ex-smoker reactions to cigarettes claiming reduced risk. Tobacco Control, 13, 78-84.
35. Shiffman, S., Pillitteri, J. L., Burton, S. L., Rohay, J. M., & Gitchell, J. G. (2001a). Effect of health messages about "light" and "ultra light" cigarettes on beliefs and quitting intent. Tobacco Control, 10, i24-i32.
36. Shiffman, S., Pillitteri, J. L., Burton, S. L., Rohay, J. M., & Gitchell, J. G. (2001b). Smokers' beliefs about "light" and "ultra light" cigarettes. Tobacco Control, 10, i17-i23.
37. Shiffman, S., Waters, A. J., & Hickcox, M. (2004). The Nicotine Dependence Syndrome Scale: A multidimensional measure of nicotine dependence. Nicotine & Tobacco Research, 6, 327-347.
38. Stepanov, I., Jensen, J., Hatsukami, D., & Hecht, S. S. (2006). Tobacco-specific nitrosamines in new tobacco products. Nicotine & Tobacco Research, 8, 309-313.
39. Tonnesen, P., Mikkelsen, K., & Bremann, L. (2008). Smoking cessation with smokeless tobacco and group therapy: An open, randomized, controlled trial. Nicotine & Tobacco Research, 10, 1365-1372.
40. Velicer, W. F., DiClemente, C. C., Rossi, J. S., & Prochaska, J. O. (1990). Relapse situations and self-efficacy: An integrative model. Addictive Behaviors, 15, 271-283.
41. Warner, K. E. (2005). Will the next generation of "safer" cigarettes be safer? Journal of Pediatric Hematology/Oncology, 27, 543-550.
42. Zhu, S., Wang, J. B., Hartman, A., Zhuang, Y., Gamst, A., Gibson, J. T., et al. (2009). Quitting cigarettes completely or switching to smokeless: Do U.S. data replicate the Swedish results. Tobacco Control, 18, 82-87.